TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34129743

Group type: EXPERIMENTAL
Intervention: Standardised exercise programme for the jaw and orofacial muscles and individualised oral hygiene programme
Number of subjects: 29
Study: 32092113

Group type: COMPARATOR
Intervention: sensor-only CPR
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: sensor-feedback CPR
Number of subjects: 292
Study: 35964867

Group type: EXPERIMENTAL
Intervention: LARKSPUR intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Emotion reporting/attention control
Number of subjects: 90
Study: 32759888

Group type: EXPERIMENTAL
Intervention: Elevated lateral recumbent position (head and chest elevated 30°)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Regular lateral recumbent position
Number of subjects: 90
Study: 35849399

Group type: EXPERIMENTAL
Intervention: Opioid Analgesia (OA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Opioid-Free Analgesia (OFA)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both OA and OFA
Number of subjects: 76
Study: 32589670

Group type: EXPERIMENTAL
Intervention: Smooth foam roller (STH)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Grid foam roller (GRID)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Passive recovery (PAS)
Number of subjects: 33
Study: 89344702

Group type: EXPERIMENTAL
Intervention: Three reduced doses of Merck Sharp and Dohme (MSD) H‐B Vax plasma derived vaccine (2 micrograms each) given intramuscularly at monthly intervals.
Number of subjects: 1207
Study: 33573696

Group type: EXPERIMENTAL
Intervention: Nilavembu Kudineer (60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Kaba Sura Kudineer (60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Decaffeinated Tea (Placebo - 60 Ml Morning and Night after Food, along with standard Allopathy Treatment for 10 days)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nilavembu Kudineer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Kaba Sura Kudineer
Number of subjects: 120

Group type: COMPARATOR
Intervention: Decaffeinated Tea (Placebo)
Number of subjects: 120
Study: 32424455

Group type: EXPERIMENTAL
Intervention: Ventral Mesh Rectopexy (VMR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pelvic Organ Prolapse Suspension (POPS)
Number of subjects: 120
Study: 34714139

Group type: EXPERIMENTAL
Intervention: RI aqueous extract fluid of 1.78 mg/mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RI aqueous extract fluid of 2.66 mg/mL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (plain water)
Number of subjects: 30
Study: 34791548

Group type: EXPERIMENTAL
Intervention: NIPSA + EMD
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NIPSA + EMD + BS
Number of subjects: 24
Study: 33852339

Group type: EXPERIMENTAL
Intervention: PARP inhibitors (PARPi) - olaparib and talazoparib, provided in capsule form
Number of subjects: 28
Study: 33147665

Group type: EXPERIMENTAL
Intervention: Ingenol disoxate gel (IngDsx, 0.018% for face/chest; 0.037% for scalp)
Number of subjects: 1242

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 1242
Study: 34162825

Group type: EXPERIMENTAL
Intervention: General awareness of oral cancer
Number of subjects: 5727

Group type: EXPERIMENTAL
Intervention: Knowledge of risk factors for oral cancer
Number of subjects: 5727

Group type: EXPERIMENTAL
Intervention: Educational interventions
Number of subjects: 5727
Study: 32992832

Group type: EXPERIMENTAL
Intervention: Nutritional intervention and olive oil
Number of subjects: 104
Study: 33918677

Group type: EXPERIMENTAL
Intervention: Repetitive, low-level dietary exposure to domoic acid (less than 20 ppm)
Number of subjects: 500
Study: 35908579

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIT) in the morning (08:00)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIT) in the afternoon (16:45)
Number of subjects: 15
Study: 32841261

Group type: EXPERIMENTAL
Intervention: Besifloxacin ophthalmic suspension 0.6%
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 1041
Study: 34164846

Group type: EXPERIMENTAL
Intervention: Morning Chocolate (MC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Evening Chocolate (EC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No Chocolate (N)
Number of subjects: 19
Study: 32525235

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy Continuation (MBCT-C) for 26 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Treatment as Usual (Control)
Number of subjects: 27
Study: 35416999

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 32108029

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD) - instructed to eat <20 g/carbs/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control - instructed to avoid dietary changes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Post hoc exploratory analysis of LCD
Number of subjects: 60
Study: 35984519

Group type: EXPERIMENTAL
Intervention: Periarticular infiltration (PI)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32965526

Group type: EXPERIMENTAL
Intervention: Isolate 1E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolate 26E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolate 14E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolate 7E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolate 19E
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 35382858

Group type: EXPERIMENTAL
Intervention: Mosquito Shield™, a spatial repellent incorporating transfluthrin
Number of subjects: 6120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6120
Study: 33969558

Group type: EXPERIMENTAL
Intervention: Individual interpersonal psychotherapy (IPT)
Number of subjects: 24
Study: 35685524

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 34341395

Group type: EXPERIMENTAL
Intervention: Nurse-based telephone follow-up
Number of subjects: 1890

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1890
Study: 32293810

Group type: EXPERIMENTAL
Intervention: MCT with 100 µA (Group A)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: MCT with 25 µA (Group B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham treatment (Group C)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group without intervention (Group D)
Number of subjects: 56
Study: 36152329

Group type: EXPERIMENTAL
Intervention: TOPS device
Number of subjects: 249

Group type: COMPARATOR
Intervention: TLIF
Number of subjects: 249
Study: 33682146

Group type: EXPERIMENTAL
Intervention: Multimodal nursing intervention (AMACOMPRI)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 34779087

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo/Metformin
Number of subjects: 190
Study: 34424919

Group type: EXPERIMENTAL
Intervention: Caregiver body mass index (BMI)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Home environment scores
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Child nutritional status based on WAZ
Number of subjects: 85
Study: 34978374

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32780605

Group type: EXPERIMENTAL
Intervention: Bilevel Noninvasive Ventilation (NIV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Albuterol
Number of subjects: 40
Study: 33559343

Group type: EXPERIMENTAL
Intervention: nanocurcumin
Number of subjects: 54

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 54
Study: 32586293

Group type: EXPERIMENTAL
Intervention: Web-based intervention group
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Blended intervention group combining web-based components with face-to-face workshops and posters
Number of subjects: 495

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 495
Study: 36416118

Group type: EXPERIMENTAL
Intervention: Navtemadlin (KRT-232)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best available therapy
Number of subjects: 0
Study: 34179755

Group type: EXPERIMENTAL
Intervention: Lidocaine trigger point injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Physiological saline interfascial injection
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 80
Study: 32599445

Group type: EXPERIMENTAL
Intervention: Chronic Depression (CD)
Number of subjects: 1013

Group type: EXPERIMENTAL
Intervention: Depression with Multiple Episodes (ME)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Depression with Few Episodes (FE)
Number of subjects: 1013
Study: 616117791

Group type: EXPERIMENTAL
Intervention: Emulsion drop containing phosphatidylethanolamine (PE) (Systane Balance, Alcon)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Liposomal spray containing phosphatidylcholine (PC) (Tears again, BioRevive)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control saline drop
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control saline spray
Number of subjects: 10
Study: 35399839

Group type: EXPERIMENTAL
Intervention: Quality care intervention for 12 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Routine care intervention
Number of subjects: 74
Study: 32216042

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplant (HSCT)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Chemotherapy-only group
Number of subjects: 132

Group type: COMPARATOR
Intervention: High-risk group
Number of subjects: 132

Group type: COMPARATOR
Intervention: Age ≤ 3 years old and hyperleukocytosis
Number of subjects: 132

Group type: COMPARATOR
Intervention: MLL-rearrangement
Number of subjects: 132

Group type: COMPARATOR
Intervention: FLT3-ITD
Number of subjects: 132

Group type: COMPARATOR
Intervention: Hyperleukocytosis
Number of subjects: 132

Group type: COMPARATOR
Intervention: BM blast ≥ 70%
Number of subjects: 132
Study: 35451536

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (125µg/day or 5,000 IU/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 34367654

Group type: EXPERIMENTAL
Intervention: HIIT (3-7 repetitions of 3 min at 100% of VO2peak interspersed by 1.5 min at 50% of VO2peak)
Number of subjects: 44

Group type: COMPARATOR
Intervention: MICT (60% of maximal oxygen peak, VO2peak)
Number of subjects: 44
Study: 36065795

Group type: EXPERIMENTAL
Intervention: Spironolactone (up to 50 mg/day)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Thiazides
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Blood urea concentration
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 513
Study: 32438600

Group type: COMPARATOR
Intervention: Internet-delivered intervention over a 10-week period comprising 10 modules addressing behavior change techniques associated with physical activity.
Number of subjects: 80
Study: 35440017

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich beverage
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Low-carbohydrate beverages
Number of subjects: 2008
Study: 32720189

Group type: EXPERIMENTAL
Intervention: 12-month one-to-one volunteer mentoring program
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 246
Study: 33223272

Group type: EXPERIMENTAL
Intervention: Drug treatment (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35351535

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day for 24 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32192073

Group type: EXPERIMENTAL
Intervention: FES Rowing with stimulation of vasti and soleus during drive and tibialis anterior during recovery
Number of subjects: 20
Study: 32606055

Group type: EXPERIMENTAL
Intervention: STOPS+ intervention
Number of subjects: 526

Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 526
Study: 35176971

Group type: EXPERIMENTAL
Intervention: 4-week music running program with a musical beat 7.5-10% higher than mean cadence
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (baseline period)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 4-week music running program
Number of subjects: 5
Study: 33590487

Group type: EXPERIMENTAL
Intervention: Tools of the Mind prekindergarten curriculum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Business-as-usual control condition
Number of subjects: 60
Study: 32432326

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) with higher total motile sperm count (TMC)
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) with lower total motile sperm count (TMC)
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) with patient discomfort
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) with timing from hCG injection
Number of subjects: 854
Study: 35372576

Group type: EXPERIMENTAL
Intervention: Catheter Directed Thrombolysis (CDT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Peripheral Intravenous Thrombolysis (PIT)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CDT
Number of subjects: 74

Group type: COMPARATOR
Intervention: PIT
Number of subjects: 74
Study: 34528282

Group type: EXPERIMENTAL
Intervention: 180 mg PMO once daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 360 mg PMO twice daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 540 mg PMO thrice daily
Number of subjects: 30
Study: 32635883

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 100
Study: 33964572

Group type: EXPERIMENTAL
Intervention: ALP 250 mg + EVE 2.5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ALP 200 mg + EVE 2.5 mg + EXE 25 mg
Number of subjects: 10
Study: 33832878

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2) and cisplatin (75 mg/m2) plus Best Supportive Care (BSC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ramucirumab (8 mg/kg) plus erlotinib (25 mg/day)
Number of subjects: 0
Study: 35384736

Group type: EXPERIMENTAL
Intervention: Family-Centered Lifestyle Intervention (FCLI) - six registered dietitian-led sessions focusing on physical activity, nutrition education, and behavioral counseling.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CTRL) - no intervention.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (FCLI and CTRL).
Number of subjects: 60
Study: 33811392

Group type: EXPERIMENTAL
Intervention: Initial Validation (n = 311)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Cross-Validation (n = 311)
Number of subjects: 622
Study: 35430440

Group type: EXPERIMENTAL
Intervention: Ozone exposure (200 ppb)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Clean air exposure
Number of subjects: 32
Study: 32638373

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine treatment
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Fludarabine-based polychemotherapy
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Cytarabine as a single agent
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Cytarabine combined with other chemotherapeutics (oxaliplatin and vincristine)
Number of subjects: 189
Study: 32629668

Group type: EXPERIMENTAL
Intervention: Low-dose glucocorticoids + methotrexate + hydroxychloroquine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo + methotrexate + hydroxychloroquine
Number of subjects: 80
Study: 35869733

Group type: EXPERIMENTAL
Intervention: 0.9% normal saline with 5% eucalyptus
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 120
Study: 34187541

Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (SCPB) with 0.2% ropivacaine, 15mL
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (SCPB)
Number of subjects: 136
Study: 35725261

Group type: EXPERIMENTAL
Intervention: Nurse-led volunteer support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Technology-driven pain assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of nurse-led volunteer support and technology-driven pain assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33378476

Group type: EXPERIMENTAL
Intervention: Piezocision corticotomy (PCG)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 26
Study: 33983564

Group type: EXPERIMENTAL
Intervention: 8% capsaicin cutaneous patch
Number of subjects: 12
Study: 34097048

Group type: EXPERIMENTAL
Intervention: Automated behavioral intervention (2 emails/week with feedback and tips, 1 letter/month with peer comparisons and financial incentives)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Automated behavioral intervention
Number of subjects: 602

Group type: COMPARATOR
Intervention: Control group (1 letter/month with general healthy lifestyle information)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 602
Study: 33528318

Group type: EXPERIMENTAL
Intervention: D/C/F/TAF (800/150/200/10 mg)
Number of subjects: 1125
Study: 36429745

Group type: EXPERIMENTAL
Intervention: VIPP-SD intervention
Number of subjects: 445
Study: 33826656

Group type: EXPERIMENTAL
Intervention: Metformin (doses ranging from 500-1500mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiologically based pharmacokinetic (PBPK) model for metformin in humans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBPK model for metformin in mice
Number of subjects: 0
Study: 32034074

Group type: EXPERIMENTAL
Intervention: Rocapuldencel-T plus standard of care (SOC)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 462
Study: 35248916

Group type: EXPERIMENTAL
Intervention: 10% body weight load
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20% body weight load
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0% body weight load (control group)
Number of subjects: 30
Study: 33115543

Group type: EXPERIMENTAL
Intervention: Imatinib (400 mg orally daily for 14 days)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo plus Best Conventional Care (BCC)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 36189751

Group type: EXPERIMENTAL
Intervention: IV push administration of levetiracetam
Number of subjects: 137

Group type: COMPARATOR
Intervention: IV piggyback administration of levetiracetam
Number of subjects: 137
Study: 33733520

Group type: EXPERIMENTAL
Intervention: Conventional chemotherapy
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Geriatric assessment (GA) tools
Number of subjects: 424
Study: 34902262

Group type: EXPERIMENTAL
Intervention: SOC plus a single subcutaneous dose of sarilumab 400 mg
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: SOC plus a single subcutaneous dose of sarilumab 200 mg
Number of subjects: 115

Group type: COMPARATOR
Intervention: SOC (control group)
Number of subjects: 115
Study: 32393092

Group type: EXPERIMENTAL
Intervention: Laughter Yoga (LY)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Relaxation Breathing
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 33380581

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich gas (HG) inhalation during a 60-minute recovery phase after exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo inhalation (ambient air) during a 60-minute recovery phase after exercise
Number of subjects: 8
Study: 34928519

Group type: EXPERIMENTAL
Intervention: 5 ml thin liquid bolus
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 10 ml thin liquid bolus
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 20 ml thin liquid bolus
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 10 ml thick liquid bolus
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pre-swallow UES basal pressure
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Post-swallow UES contractile integral
Number of subjects: 19
Study: 32312337

Group type: EXPERIMENTAL
Intervention: Fish oil (containing at least 250 mg DHA and at least 60 mg EPA)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 420
Study: 35043869

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral erector spinae plane block combined with intravenous patient-controlled analgesia (iv PCA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (iv PCA) alone
Number of subjects: 50
Study: 34096642

Group type: EXPERIMENTAL
Intervention: Providing information on public benefits of bed net use and others' bed net use
Number of subjects: 0
Study: 32214333

Group type: EXPERIMENTAL
Intervention: Electronic chart review
Number of subjects: 78

Group type: COMPARATOR
Intervention: Paper chart review
Number of subjects: 78
Study: 35876440

Group type: EXPERIMENTAL
Intervention: MedLift (Prostatic Urethral Lift)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 187

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 187
Study: 33975490

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined CPAP and Sham CPAP
Number of subjects: 47
Study: 32859328

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional diabetes (CD) diet
Number of subjects: 16
Study: 36380601

Group type: EXPERIMENTAL
Intervention: EVERYbody Project
Number of subjects: 90

Group type: COMPARATOR
Intervention: Video-based, low-dissonance comparison intervention
Number of subjects: 90